Galβ(1-3)GalNAc

Suppliers

Names

[ CAS No. ]:
20972-29-6

[ Name ]:
Galβ(1-3)GalNAc

[Synonym ]:
Osmolactan
SUGAR MILK
T-Antigen
Aletobiose
LACTOBIOSE
galacto-N-biose
D-LACTOSE
beta-D-Galp-(1->3)-D-GalpNAc
Galactinum
LACTIN
lactose aldehyde form

Chemical & Physical Properties

[ Density]:
1.64 g/cm3

[ Boiling Point ]:
795.5ºC at 760 mmHg

[ Melting Point ]:
159-160ºC

[ Molecular Formula ]:
C14H25NO11

[ Molecular Weight ]:
383.34800

[ Flash Point ]:
434.9ºC

[ Exact Mass ]:
383.14300

[ PSA ]:
198.40000

[ Vapour Pressure ]:
2.95E-29mmHg at 25°C

[ Index of Refraction ]:
1.623

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

Synthetic Route

Precursor & DownStream

Precursor

  • N-acelyl-D-glucosamine
  • 4-Nitrophenyl β-D-galactopyranoside
  • d-(+)-galactose
  • (2S,3S,4S,5R,6R)-2-(((4aR,6S,7R,8R,8aS)-7-acetamido-6-(benzyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-8-yl)oxy)-6-(acetoxymethyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
  • benzyl 2-acetamido-4-O-benzoyl-6-O-benzyl-2-deoxy-3-O-(2,3,4,6,tetra-O-acetyl-β-D-galactopyranosyl)-β-D-galactopyranoside
  • sucrose

DownStream

Articles

Sp1 sites in the noncoding control region of BK polyomavirus are key regulators of bidirectional viral early and late gene expression.

J. Virol. 89(6) , 3396-411, (2015)

In kidney transplant patients with BK polyomavirus (BKPyV) nephropathy, viral variants arise bearing rearranged noncoding control regions (rr-NCCRs) that increase viral early gene expression, replicat...

Chromosome Missegregation Associated with RUVBL1 Deficiency.

PLoS ONE 10 , e0133576, (2015)

RUVBL1 (RuvB-like1) and RUVBL2 (RuvB-like 2) are integral components of multisubunit protein complexes involved in processes ranging from cellular metabolism, transcription and chromatin remodeling to...

Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR.

Nat. Commun. 5 , 5582, (2014)

Solid tumours are exposed to microenvironmental factors such as hypoxia that normally inhibit cell growth. However, tumour cells are capable of counteracting these signals through mechanisms that are ...


More Articles


Related Compounds

  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 5-(Aminomethyl)-2-(trifluoromethyl)benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • Tert-butyl3-(2-hydroxyethyl)-2-methylazetidine-1-carboxylate
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • (2S,3S)-3-Methyl-1,4-dioxane-2-carboxylic acid
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde